Merck & Co vs UnitedHealth Group

Merck & Co (MRK), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Merck & Co and UnitedHealth Group are valued at about the same: $354.4B and $357.1B. Merck & Co trades at 145 times earnings and UnitedHealth Group at 22.7. Over the past year Merck & Co's share price has moved +49.8% and UnitedHealth Group's +31.4%.

Key facts

Merck & Co market value
$354.4B
UnitedHealth Group market value
$357.1B
Merck & Co P/E
145
UnitedHealth Group P/E
22.7
Merck & Co revenue
$65BFY to 2025-12-31
UnitedHealth Group revenue
$447.6BFY to 2025-12-31
Superinvestors holding both
11

Market values as of .

Merck & Co vs UnitedHealth Group: every measure side by side
Measure Merck & Co UnitedHealth Group
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$354.4Blower$357.1Bhigher
Revenue$65Blower$447.6Bhigher
Earnings$18.3Bhigher$12.1Blower
Employees73,000lower390,000higher
Total assets$136.9Blower$309.6Bhigher
Valuation
P/E145higher22.7lower
P/S5.5higher0.8lower
P/B7.9higher3.6lower
Dividend yield2.33%higher2.20%lower
Profitability
Operating margin—4.24%
Balance sheet
Net assets$52.6Blower$100.1Bhigher
Total liabilities$84.2Blower$207.9Bhigher
Total debt$49.3Blower$77.7Bhigher
Cash on hand$14.6Blower$24.4Bhigher
Price change
Today-0.48%higher-3.27%lower
1 year+49.8%higher+31.4%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Merck & Co / UnitedHealth Group). Who owns MRK · Who owns UNH

Further comparisons

Learn

Questions and answers

Which is bigger, Merck & Co or UnitedHealth Group?

By market value, UnitedHealth Group is the larger: $357.1B against $354.4B for Merck & Co. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $65B for Merck & Co.

Which has the higher P/E ratio?

Merck & Co: 145, against 22.7 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher dividend yield?

Merck & Co: 2.33%, against 2.20% for UnitedHealth Group. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

UnitedHealth Group: $77.7B, against $49.3B for Merck & Co. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Merck & Co and UnitedHealth Group?

In their latest 13F filings, Bill Smead, Ken Fisher, Jeremy Grantham (co-founder), Charles Brandes (founder), Sarah Ketterer, Cliff Asness, Temasek, Ken Griffin, Mairs & Power team, Dodge & Cox team and Rajiv Jain hold both.

Cite this page

Funkfolio, “Merck & Co vs UnitedHealth Group”, data as of 17 November 2026. https://funkfolio.com/compare/mrk-vs-unh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.